ABC | Volume 114, Nº6, Junho 2020

Artigo Original Yurre et al. Avaliação dos efeitos cardíacos de WSMoL Arq Bras Cardiol. 2020; 114(6):1029-1037 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 37. Lehr CM. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Crit Rev Ther Drug Carrier Syst. 1994;11(2-3):119-60. 38. Zhao YT, Wang L, Yi Z. An unusual etiology for bidirectional ventricular tachycardia. Can J Cardiol. 2016;32(3):395.e5-6. 39. HanSN,YangSH,ZhangY,DuanYY,SunXY,ChenQ,etal.BlockageofhERG current and the disruption of trafficking as induced by roxithromycin. Can J Physiol Pharmacol. 2013;91(12):1112-8. 40. Kauthale RR, Dadarkar SS, Husain R, Karande VV, Gatne MM. Assessment of temperature-induced hERG channel blockade variation by drugs. J Appl Toxicol. 2015;35(7):799-805. 41. Nogawa H, Kawai T, Yajima M, Miura M, Ogawa T, Murakami K. Effects of probucol, a typical hERG expression inhibitor, on in vivo QT interval prolongation in conscious dogs. Eur J Pharmacol. 2013;720(1-3):29-37. 42. Guo J, Zhan S, Lees-Miller JP, Teng G, Duff HJ. Exaggerated block of hERG (KCNH2) and prolongation of action potential duration by erythromycin at temperatures between 37 degrees C and 42 degrees C. Heart Rhythm. 2005;2(8):860-6. 43. ZhangM, XieM, Li S, Gao Y, Xue S, HuangH, et al. Electrophysiologic studies on the risks and potential mechanism underlying the proarrhythmic nature of azithromycin. Cardiovasc Toxicol. 2017;17(4):434-40. 44. Singh R, Sripada L, Singh R. Side effects of antibiotics during bacterial infection: mitochondria, the main target in host cell. Mitochondrion. 2014 May;16:50-4. 45. Warmbrunn, MV, Schilling JM, Dhanani M, Glukhov E, Gerwick LG, Gerwick WH, et al. Novel marine compounds modulate mitochondrial function in H9c2 cells: potential new pharmaceutical targets to control cardiac metabolism. FASEB J. 2018;32(1 suppl):702.1. 1037